{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:24:35Z","timestamp":1793949875553,"version":"4.8.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01EB027797"],"award-info":[{"award-number":["R01EB027797"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA062203"],"award-info":[{"award-number":["P30CA062203"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016829","name":"UC Irvine Materials Research Institute","doi-asserted-by":"publisher","award":["R01GM129325"],"award-info":[{"award-number":["R01GM129325"]}],"id":[{"id":"10.13039\/100016829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biomaterials.2026.124128","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:44:22Z","timestamp":1773474262000},"page":"124128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanoparticle-mediated dual delivery of MHC class I and II antigens enhances T cell immunity and anti-tumor potency"],"prefix":"10.1016","volume":"333","author":[{"given":"Enya","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1097-2647","authenticated-orcid":false,"given":"Nina","family":"Butkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-4269","authenticated-orcid":false,"given":"Jo A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7398-0220","authenticated-orcid":false,"given":"Szu-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124128_bib1","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.3889\/oamjms.2019.735","article-title":"Myeloid and plasmacytoid dendritic cells and cancer - new insights","volume":"7","author":"Gulubova","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/j.biomaterials.2026.124128_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic cells revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/cancers16122211","article-title":"Dendritic cells in shaping anti-tumor T cell response","volume":"16","author":"Mazzoccoli","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biomaterials.2026.124128_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nano.2018.09.004","article-title":"Protein-based nanoparticles in cancer vaccine development","volume":"15","author":"Neek","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biomaterials.2026.124128_bib5","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/molecules26113382","article-title":"A review on cancer immunotherapy and applications of nanotechnology to chemoimmunotherapy of different cancers","volume":"26","author":"Akk\u0131n","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2026.124128_bib6","article-title":"An antigen-delivery protein nanoparticle combined with anti-PD-1 checkpoint inhibitor has curative efficacy in an aggressive melanoma model","volume":"3","author":"Neek","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biomaterials.2026.124128_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-024-07752-y","article-title":"Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy","volume":"632","author":"Sultan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124128_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00262-018-2274-1","article-title":"A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma","volume":"68","author":"Tsuboi","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biomaterials.2026.124128_bib9","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.7150\/thno.71760","article-title":"Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy","volume":"12","author":"Shi","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124128_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124128_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1771925","article-title":"A liposomal RNA vaccine inducing neoantigen-specific CD4(+) T cells augments the antitumor activity of local radiotherapy in mice","volume":"9","author":"Salomon","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.biomaterials.2026.124128_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2019.02.002","article-title":"Studying interactions between dendritic cells and T cells in vivo","volume":"58","author":"Chudnovskiy","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/BST20210961","article-title":"Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance","volume":"50","author":"Balasubramanian","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biomaterials.2026.124128_bib14","first-page":"2543","article-title":"Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines","volume":"116","author":"McMahan","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2026.124128_bib15","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1073\/pnas.0914879107","article-title":"Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens","volume":"107","author":"Jordan","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2026.124128_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.actbio.2022.01.004","article-title":"Antigen epitope-TLR7\/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy","volume":"141","author":"Song","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2026.124128_bib17","article-title":"Human ferritin platform and its optimized structures to enhance anti-cancer immunity","volume":"4","author":"Lee","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biomaterials.2026.124128_bib18","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1016\/j.vaccine.2006.06.003","article-title":"TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models","volume":"24","author":"McCormick","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2026.124128_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41587-019-0390-x","article-title":"Peptide\u2013TLR-7\/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens","volume":"38","author":"Lynn","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00262-004-0655-0","article-title":"Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma","volume":"54","author":"Brinkman","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biomaterials.2026.124128_bib21","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib22","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-025-58289-1","article-title":"Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse","volume":"16","author":"Heras-Murillo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124128_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.biomaterials.2026.124128_bib24","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4049\/jimmunol.1600591","article-title":"Immediate dysfunction of vaccine-elicited CD8+ T cells primed in the absence of CD4+ T cells","volume":"197","author":"Provine","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib25","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1126\/science.1072615","article-title":"A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory","volume":"297","author":"Bourgeois","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124128_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00018-017-2686-7","article-title":"CD4 and CD8 T lymphocyte interplay in controlling tumor growth","volume":"75","author":"Ostroumov","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124128_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124128_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124128_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180644","article-title":"CD4\/CD8\/Dendritic cell complexes in the spleen: CD8+ T cells can directly bind CD4+ T cells and modulate their response","volume":"12","author":"Barinov","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2026.124128_bib31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4049\/jimmunol.177.3.1406","article-title":"Cutting edge: cognate CD4 help promotes recruitment of antigen-specific CD8 T cells around dendritic cells","volume":"177","author":"Beuneu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110632","article-title":"Autocrine and paracrine IL-2 signals collaborate to regulate distinct phases of CD8 T cell memory","volume":"39","author":"Toumi","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2026.124128_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/CJI.0000000000000231","article-title":"Tumor regression and cure depends on sustained Th1 responses","volume":"41","author":"Dai","year":"2018","journal-title":"J. Immunother."},{"key":"10.1016\/j.biomaterials.2026.124128_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biomaterials.2016.01.056","article-title":"Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses","volume":"86","author":"Molino","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124128_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.147.1.1","article-title":"Differential expression of an equivalent clonotype among BALB\/c and C57BL\/6 mice","volume":"147","author":"Cancro","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2026.124128_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1124\/mol.106.024547","article-title":"Apigenin inhibits immunostimulatory function of dendritic cells: implication of immunotherapeutic adjuvant","volume":"70","author":"Yoon","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib38","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.4049\/jimmunol.1300467","article-title":"Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity","volume":"191","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.omto.2021.04.009","article-title":"Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition","volume":"21","author":"Stolk","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.biomaterials.2026.124128_bib40","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1158\/0008-5472.CAN-05-1973","article-title":"A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope","volume":"65","author":"R\u00f6hn","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124128_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1074-7613(00)00052-2","article-title":"Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex","volume":"13","author":"Slansky","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2026.124128_bib42","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1021\/nn403085w","article-title":"Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation","volume":"7","author":"Molino","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124128_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biomaterials.2017.11.022","article-title":"Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses","volume":"156","author":"Neek","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124128_bib44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1039\/D2BM01132H","article-title":"Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display","volume":"11","author":"Butkovich","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biomaterials.2026.124128_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/bit.21988","article-title":"Thermostability and molecular encapsulation within an engineered caged protein scaffold","volume":"101","author":"Dalmau","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biomaterials.2026.124128_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/nl8027069","article-title":"Design of a pH-Dependent molecular switch in a caged protein platform","volume":"9","author":"Dalmau","year":"2009","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2026.124128_bib47","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/v14071493","article-title":"Understanding immune responses to viruses\u2014do underlying Th1\/Th2 cell biases predict outcome?","volume":"14","author":"Howard","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.biomaterials.2026.124128_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and regulation of Th cells: a balancing act for cancer immunotherapy","volume":"12","author":"Basu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2026.124128_bib50","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2353\/ajpath.2008.070776","article-title":"Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis","volume":"172","author":"Schulte","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000117","article-title":"T-helper type 1 bias in healthy people is associated with cytomegalovirus serology and atherosclerosis: the multi-ethnic study of atherosclerosis","volume":"2","author":"Tracy","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biomaterials.2026.124128_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12026-014-8517-0","article-title":"Effects of stress on immune function: the good, the bad, and the beautiful","volume":"58","author":"Dhabhar","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biomaterials.2026.124128_bib53","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2014.57.4079","article-title":"Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial","volume":"33","author":"Wenzel","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib54","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/acsbiomaterials.7b00148","article-title":"Display of DNA on nanoparticles for targeting antigen presenting cells","volume":"3","author":"Molino","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2026.124128_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: induction of \"self\"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2026.124128_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-0716-3222-2_18","article-title":"Evaluating anti-tumor immune responses of protein nanoparticle-based cancer vaccines","volume":"2671","author":"Li","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1023\/A:1020687518999","article-title":"Plant lectins: occurrence, biochemistry, functions and applications","volume":"18","author":"R\u00fcdiger","year":"2001","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.biomaterials.2026.124128_bib58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41541-021-00330-7","article-title":"Protein-based antigen presentation platforms for nanoparticle vaccines","volume":"6","author":"Nguyen","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.biomaterials.2026.124128_bib60","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1021\/bm300083e","article-title":"Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules","volume":"13","author":"Molino","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2026.124128_bib61","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/smll.201002242","article-title":"Protein nanocapsules containing doxorubicin as a pH-responsive delivery system","volume":"7","author":"Ren","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124128_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bej.2013.09.008","article-title":"Engineered drug-protein nanoparticle complexes for folate receptor targeting","volume":"89","author":"Ren","year":"2014","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.biomaterials.2026.124128_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/849573","article-title":"Epigenetic control of interferon-gamma expression in CD8 T cells","volume":"2015","author":"de Ara\u00fajo-Souza","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biomaterials.2026.124128_bib64","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1021\/acs.bioconjchem.3c00317","article-title":"Engineering protein nanoparticles functionalized with an immunodominant Coxiella burnetii antigen to generate a Q fever vaccine","volume":"34","author":"Ramirez","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2026.124128_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.actbio.2018.06.029","article-title":"\u03b1-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma","volume":"76","author":"Sainz","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2026.124128_bib66","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41565-019-0512-0","article-title":"Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators","volume":"14","author":"Conniot","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/cells1020127","article-title":"Dissecting the T cell response: proliferation assays vs. cytokine signatures by ELISPOT","volume":"1","author":"Anthony","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124128_bib68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1074-7613(00)00029-7","article-title":"Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo","volume":"13","author":"Laouar","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2026.124128_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib70","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.4049\/jimmunol.177.7.4257","article-title":"Cutting edge: paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response","volume":"177","author":"Long","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coi.2017.07.004","article-title":"Vaccines targeting helper T cells for cancer immunotherapy","volume":"47","author":"Melssen","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib73","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.biomaterials.2026.124128_bib74","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2164-15-190","article-title":"Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma","volume":"15","author":"Castle","year":"2014","journal-title":"BMC Genom."},{"key":"10.1016\/j.biomaterials.2026.124128_bib76","article-title":"A potent micron neoantigen tumor vaccine GP-neoantigen induces robust antitumor activity in multiple tumor models","volume":"9","author":"Jing","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.biomaterials.2026.124128_bib77","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2026.124128_bib78","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib79","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","article-title":"The role of Interleukin 6 during viral infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627932","article-title":"Cancer vaccines, adjuvants, and delivery systems","volume":"12","author":"Paston","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41541-025-01118-9","article-title":"Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer","volume":"10","author":"Shah","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.biomaterials.2026.124128_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101435","article-title":"Memory CD8(+) T cell responses to cancer","volume":"49","author":"Han","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn9961","article-title":"Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity","volume":"10","author":"Fan","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124128_bib84","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.0306407101","article-title":"T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node","volume":"101","author":"Miller","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2026.124128_bib85","doi-asserted-by":"crossref","first-page":"810","DOI":"10.21037\/tlcr-24-886","article-title":"Closer proximity of pre-treatment CD4(+) T cells to CD8(+) T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer","volume":"14","author":"Yang","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124128_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adq8843","article-title":"Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4(+) T cell response","volume":"9","author":"Chudnovskiy","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib87","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1158\/1541-7786.MCR-21-0411","article-title":"The spatial context of tumor-infiltrating immune cells associates with improved ovarian cancer survival","volume":"19","author":"Steinhart","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124128_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112212","article-title":"MHC2-SCALE enhances identification of immunogenic neoantigens","volume":"28","author":"Gober","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.biomaterials.2026.124128_bib89","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41551-022-01000-2","article-title":"Multi-antigen spherical nucleic acid cancer vaccines","volume":"7","author":"Teplensky","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2026.124128_bib90","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib91","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0952-7915(98)80228-8","article-title":"The role of CD4+ T cell responses in antitumor immunity","volume":"10","author":"Pardoll","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124128_bib92","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ccell.2024.05.025","article-title":"Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors","volume":"42","author":"Espinosa-Carrasco","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2026.124128_bib93","article-title":"Modularly programmable nanoparticle vaccine based on polyethyleneimine for personalized cancer immunotherapy","volume":"8","author":"Nam","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.biomaterials.2026.124128_bib94","first-page":"2553","article-title":"Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124128_bib95","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.canlet.2005.04.012","article-title":"Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4","volume":"235","author":"Pedersen","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124128_bib96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2011.06325.x","article-title":"The blessings and curses of C57BL\/6 substrains in mouse genetic studies","volume":"1245","author":"Bryant","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2026.124128_bib97","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:11Z","timestamp":1793946371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":97,"alternative-id":["S0142961226001523"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124128","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-mediated dual delivery of MHC class I and II antigens enhances T cell immunity and anti-tumor potency","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"124128"}}